Description: Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection products of 20 varieties with 44 specifications of the injection drug approval number. The company's products include xingnaojing, shenmai, and astragalus injections, as well as leucocin A and citicoline injections. It also has 31 patents, including 11 invention patents, 16 utility models, and 3 design patents. The company was founded in 1996 and is headquartered in Dali, China.
Home Page: www.daliyaoye.cn
No. 118, West Huancheng Road
Dali,
671000
China
Phone:
86 87 1683 58699
Officers
| Name | Title |
|---|---|
| Mr. Jun Xiang Yang | Chairman & GM |
| Mr. Shao Yun Li | Chief Financial Officer |
| Mr. Xian Guo Li | Exec. Deputy GM & Sec. of the Board |
| Mr. Jun Wei Yang | Assistant GM, Supply Mang. & Director |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.3214 |
| Price-to-Sales TTM: | 22.91 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 298 |